These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 38118007)

  • 21. Laboratory-based surveillance of antimicrobial resistance in regions of Kenya: An assessment of capacities, practices, and barriers by means of multi-facility survey.
    Moirongo RM; Aglanu LM; Lamshöft M; Adero BO; Yator S; Anyona S; May J; Lorenz E; Eibach D
    Front Public Health; 2022; 10():1003178. PubMed ID: 36518572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of antimicrobial resistance laboratory-based surveillance capacity of hospitals in Zambia: findings and implications for system strengthening.
    Yamba K; Chizimu JY; Mudenda S; Lukwesa C; Chanda R; Nakazwe R; Simunyola B; Shawa M; Kalungia AC; Chanda D; Mateele T; Thapa J; Kapolowe K; Mazaba ML; Mpundu M; Masaninga F; Azam K; Nakajima C; Suzuki Y; Bakyaita NN; Wesangula E; Matu M; Chilengi R
    J Hosp Infect; 2024 Jun; 148():129-137. PubMed ID: 38621513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol for surveillance of antimicrobial-resistant bacteria causing community-acquired urinary tract infections in low-income countries.
    Majigo MV; Mshana S; Komba E; Moremi N; Matee M
    PLoS One; 2024; 19(5):e0304388. PubMed ID: 38820392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of an antibiotic resistance surveillance tool in Madagascar, the TSARA project: a prospective, observational, multicentre, hospital-based study protocol.
    Elias C; Raad M; Rasoanandrasana S; Raherinandrasana AH; Andriananja V; Raberahona M; Moore CE; Randria M; Raskine L; Vanhems P; Babin FX
    BMJ Open; 2024 Mar; 14(3):e078504. PubMed ID: 38508637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coverage of policies to improve antimicrobial stewardship in human medicine in low and middle income countries: results from the Global Survey of Experts on Antimicrobial Resistance.
    Zay Ya K; Lambiris MJ; Levine GA; Tediosi F; Fink G
    BMC Public Health; 2024 Aug; 24(1):2297. PubMed ID: 39180027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating Scalable Genome Sequencing Into Microbiology Laboratories for Routine Antimicrobial Resistance Surveillance.
    Kekre M; Arevalo SA; Valencia MF; Lagrada ML; Macaranas PKV; Nagaraj G; Oaikhena AO; Olorosa AM; Aanensen DM;
    Clin Infect Dis; 2021 Dec; 73(Suppl_4):S258-S266. PubMed ID: 34850836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
    Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Building resilient and responsive research collaborations to tackle antimicrobial resistance-Lessons learnt from India, South Africa, and UK.
    Veepanattu P; Singh S; Mendelson M; Nampoothiri V; Edathadatil F; Surendran S; Bonaconsa C; Mbamalu O; Ahuja S; Birgand G; Tarrant C; Sevdalis N; Ahmad R; Castro-Sanchez E; Holmes A; Charani E
    Int J Infect Dis; 2020 Nov; 100():278-282. PubMed ID: 32860949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a Sentinel Laboratory-Based Antimicrobial Resistance Surveillance Network in Ethiopia.
    Hazim C; Abubeker Ibrahim R; Westercamp M; Belete GA; Amare Kibret B; Kanter T; Yimer G; Adem TS; Stevenson KB; Urrego M; Kale KN; Omondi MW; VanderEnde D; Park BJ; Parsons MMB; Gallagher KM
    Health Secur; 2018; 16(S1):S30-S36. PubMed ID: 30480505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The European gonococcal antimicrobial surveillance programme (Euro-GASP) appropriately reflects the antimicrobial resistance situation for Neisseria gonorrhoeae in the European Union/European Economic Area.
    Cole MJ; Quinten C; Jacobsson S; Day M; Amato-Gauci AJ; Woodford N; Spiteri G; Unemo M;
    BMC Infect Dis; 2019 Dec; 19(1):1040. PubMed ID: 31822275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing antimicrobial resistance in low and middle-income countries: overcoming challenges and implementing effective strategies.
    Rony MKK; Sharmi PD; Alamgir HM
    Environ Sci Pollut Res Int; 2023 Sep; 30(45):101896-101902. PubMed ID: 37610548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings.
    Okeke IN; Feasey N; Parkhill J; Turner P; Limmathurotsakul D; Georgiou P; Holmes A; Peacock SJ
    BMJ Glob Health; 2020 Dec; 5(12):. PubMed ID: 33268385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
    European Antimicrobial Resistance Collaborators
    Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimicrobial resistance in the Pacific Island countries and territories.
    Loftus M; Stewardson A; Naidu R; Coghlan B; Jenney A; Kepas J; Lavu E; Munamua A; Peel T; Sahai V; Tekoaua R; Tudravu L; Zinihite J; Cheng A; Rafai E; Peleg A
    BMJ Glob Health; 2020 Apr; 5(4):. PubMed ID: 32349993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation and mapping of the surveillance system for antimicrobial resistance and antimicrobial use in the United Kingdom.
    Bennani H; Cornelsen L; Stärk KDC; Häsler B
    Vet Rec; 2021 Apr; 188(7):e10. PubMed ID: 33835538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Filling the gaps in the global prevalence map of clinical antimicrobial resistance.
    Oldenkamp R; Schultsz C; Mancini E; Cappuccio A
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33372157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of diagnostic network optimization in Kenya and Nepal to design integrated, sustainable and efficient bacteriology and antimicrobial resistance surveillance networks.
    Brunetti M; Singh A; Chebore S; Gyenwali D; Malou N; Ferreyra C; Gompo TR; Chapagain S; Githii S; Wesangula E; Albert H
    PLOS Glob Public Health; 2023; 3(12):e0002247. PubMed ID: 38055687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India.
    Singh S; Charani E; Devi S; Sharma A; Edathadathil F; Kumar A; Warrier A; Shareek PS; Jaykrishnan AV; Ellangovan K
    Antimicrob Resist Infect Control; 2021 Feb; 10(1):32. PubMed ID: 33573697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMR in low-resource settings: Médecins Sans Frontières bridges surveillance gaps by developing a turnkey solution, the Mini-Lab.
    Ronat JB; Natale A; Kesteman T; Andremont A; Elamin W; Hardy L; Kanapathipillai R; Michel J; Langendorf C; Vandenberg O; Naas T; Kouassi F
    Clin Microbiol Infect; 2021 Oct; 27(10):1414-1421. PubMed ID: 33932617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The challenges and successes of implementing a sustainable antimicrobial resistance surveillance programme in Nepal.
    Malla S; Dumre SP; Shakya G; Kansakar P; Rai B; Hossain A; Nair GB; Albert MJ; Sack D; Baker S; Rahman M;
    BMC Public Health; 2014 Mar; 14():269. PubMed ID: 24650008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.